InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Lee Jacks. Director active across 2 companies, notably G1 Therapeutics, Inc.. In total, 4 reports have been published. Activity tracked since 15 June 2023. The latest transaction was disclosed on 13 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations